WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001022992) INFLUENZA VACCINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/022992    International Application No.:    PCT/EP2000/009509
Publication Date: 05.04.2001 International Filing Date: 27.09.2000
Chapter 2 Demand Filed:    04.04.2001    
IPC:
A61K 39/145 (2006.01), C12N 7/02 (2006.01)
Applicants: SMITHKLINE BEECHAM BIOLOGICALS S.A. [BE/BE]; Rue de l'Institut 89, B-1330 Rixensart (BE) (For All Designated States Except US).
SAECHSISCHES SERUMWERK DRESDEN [DE/DE]; Branch of SmithKline Beecham Pharma GmbH, Zirkusstrasse 40, 01069 Dresden (DE) (For All Designated States Except US).
D'HONDT, Erik [BE/BE]; (BE) (For US Only).
HEHME, Norbert [DE/DE]; (DE) (For US Only)
Inventors: D'HONDT, Erik; (BE).
HEHME, Norbert; (DE)
Agent: PRIVETT, Kathryn, Louise; SmithKline Beecham, Corporate Intellectual Property (CN9.25.1), 980 Great West Road, Brentford, Middlesex TW8 9GS (GB).
DALTON, Marcus, Jonathan, William; GlaxoSmithKline, Corporate Intellectual Property (CN9.25.1), 980 Great West Road, Brentford, Middlesex TW8 9GS (GB)
Priority Data:
9923176.3 30.09.1999 GB
Title (EN) INFLUENZA VACCINE
(FR) NOUVELLE COMPOSITION
Abstract: front page image
(EN)The invention provides a monovalent influenza vaccine comprising a low dose of egg-derived influenza virus antigen from an influenza virus strain that is associated with a pandemic outbreak or has the potential to be associated with a pandemic outbreak, in combination with an aluminium adjuvant. The invention also provides vaccine kits comprising a combination of a parenteral and a mucosal influenza vaccine, wherein the combined dose of antigen is no more than the conventional antigen dose. Also provided are methods for preparing the vaccines.
(FR)L'invention concerne un vaccin monovalent contre la grippe comprenant une faible dose d'antigène du virus de la grippe dérivé de l'oeuf, d'une souche de virus associée à une pandémie ou ayant le potentiel d'être associée à une pandémie, combinée à un adjuvant aluminium. L'invention concerne également des kits de vaccins comprenant une combinaison de vaccins contre la grippe parentéraux et des muqueuses, dans lesquels la dose combinée d'antigène n'est pas supérieure à la dose d'antigène habituelle. L'invention concerne également des procédés de préparation des vaccins.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)